Home » today » Health » The new lab will more than double the UK’s Covid testing capability by 2021 World News

The new lab will more than double the UK’s Covid testing capability by 2021 World News

The UK’s Covid-19 testing capability will more than double, and a new large laboratory will open early next year as a sign that the government plans to continue the pandemic, despite hopes from a number of potential vaccinations. .

The facilities, one at Leamington Spa and the other in an unidentified location in Scotland, will employ up to 4,000 people and increase the number of PCR tests – the gold standard water tests already used in the UK – that are carried out every day. with 600,000 can be processed, from the current 520,000.

The government said a “megalaboratory” would speed up processing of tests, while the health secretary, Matt Hancock, said it would be useful to “provide our nationally resilient infrastructure to respond to future epidemics”.

The laboratory will be active and operational in the first months of next year, the Department Health and Social Care (DHSC) said last night. There are no details on the costs or who will manage them.

A leading scientist behind the BioNTech / Pfizer vaccine candidate, which passed interim clinical trials and demonstrated 90% effectiveness in preventing sick people, said on Sunday that he was “very confident” it will also reduce transmission of the corona virus with “maybe 50%”.

Prof Ugur Sahin, CEO of BioNTech, told the BBC that the goal is to return to normal by the coming winter, with a vaccine program launched in 2021.

His comments and the construction of a new laboratory reinforce warnings that the end of the pandemic is still months away. However, the head of the Office for National Statistics, Prof. Sir Ian Diamond, on Sunday confirmed the “slowdown in growth rates” in cases across the country.

video caption caption--img">
Has our new Covid vaccine returned to normal? – video layout

With two weeks left of restrictions in the UK, Prof Susan Michie, a member of Sage, said over the weekend the public must fight against the rule violation so I can see family over Christmas. Prof John Edmunds, another Sage member, added: “We need to take a long-term and prudent view and realize that we have to put some restrictions in place for some time.”

Except for the BioNTech / Pfizer vaccines, some of these may be ready to launch before Christmas, as long as results and approvals go as expected. more than 170 other vaccine candidates are in development, 11 of them are currently in phase 3 efficacy testing.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.